ISTA Pharmaceuticals, Inc. (ISTA) Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI)
11/9/2009 8:31:18 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Reports Third Quarter 2009 Financial Results
11/4/2009 7:50:42 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) to Present at 2009 BIOCOM Investor Conference
10/20/2009 11:12:14 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces Conference Call and Webcast of Third Quarter 2009 Financial Results
10/2/2009 10:43:23 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces Preliminary Results of T-Pred Studies
9/9/2009 8:38:32 AM
More...
|
FDA Approves ISTA Pharmaceuticals, Inc. (ISTA)'s Itchy Eye Treatment Bepreve
9/9/2009 7:17:04 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
8/26/2009 6:55:43 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Reports Second Quarter 2009 Financial Results and Raises Full Year Revenue Guidance
8/6/2009 11:32:26 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces Conference Call and Webcast of Second Quarter 2009 Financial Results
7/29/2009 9:37:20 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Wins US Panel Support for Eye Itch Drug
6/26/2009 8:16:54 AM
More...
|
|